Articles On Micro-X (ASX:MX1)

The RangeHawk drone has a whopping 40m wingspan and is set to test hypersonic weapons  DroneShield secures $2m contract from European Government customer for its counterdrone tech Aerospace player Quickstep has had to expand its Geelong f...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AMS)) - Atomos ((ATA)) - Atturra ((BST)) - Best & Less ((BTH)) - Bigtincan Holdings ((BBT)) - BlueBet Holdings ((BVS)) - Bravura Solutions ((BUB)) - Bubs Australia (...

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

114 tech stocks were trading down for the month of June 11 stocks flatlined and only 22 were in the green The biggest losers were iSYNERGY, Icetana and Eroad   Wowzers. Even by tech stocks standards, June was a bit of a shocker, with the...

Avita Medical makes spray on skin for burns and soft tissue injuries HITIQ’s concussion tech is popular for athletes and sports teams PainChek’s smartphone app can tell if babies or older Aussies are in pain There’s a plethora of biotech...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Google engineer reckons chatbot has become sentient Xtek sends $9.5m of specialist ballistic products to secret US customer Micro-X nabs new US distributor for its mobile Rover x-ray product   Google engineer Blake Lemoine has been sent o...

Dark clouds continue to hover over ASX health stocks Health imaging company Volpara’s FY22 results in line with expectations Fight for fertility company Virtus enters another round Healthcare and life sciences expert Scott Power – a senio...

Successful first stage design milestone for Micro-X Passenger Self screening station – Unlocks $0.7m second phase of work ADELAIDE, Australia and SEATTLE, May 24, 2022 /PRNewswire/ — Australian hi-tech company Micro-X Ltd (ASX:MX1) (Micro-X...

Healthcare and life sciences expert Scott Power – a senior analyst with Morgans Financial for 24 years – on what the movers and shakers have been doing in health and which ASX health stocks make Scott’s Powerplays. Look in the mirror and li...

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

ASX gives back early gains on Wednesday Small caps whacked as Fed Hawks get hawky, bonds get toppy, coal prices surge, oil prices plunge… again And now the market news in briefs. Unlike the no-frills, straight-shooting ASX Emerging Compan...

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

ShareCafeWebinar Recap – MX1, SPL, MAP, RFL & RAP Catch up on the full webinar with presentations from Micro-X (ASX: MX1), Starpharma (ASX: SPL), Microba Life Sciences (ASX: MAP), RLF AgTech (ASX: RFL) & ResApp (ASX: RAP) Webinar R...

ShareCafeMicro-X (ASX: MX1) – Webinar Presentation Peter Rowland – MD – Micro-X Limited designs, develops, and manufactures ultra-lightweight carbon X-ray products for healthcare. Micro-X (ASX: MX1) – Webinar PresentationCompany News

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in ASX health stocks. Good news for coffee lovers, particularly those w...

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

The ASX Emerging Companies Index (XEC) has ended 1.5% higher on Wednesday, driven by a new EV car as a few battery metal small caps locked in the right prices from a government ready to pay. The ASX200 has also risen a further 1.1% driven b...

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Everyone loves a comeback. Just...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. During his Australian Open quar...

At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform...

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %...

It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 25 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week At the time...

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week The AGM sea...

Linius pursues commercialisation of video virtualisation engine tech UBI up after nabbing new distribution deal for its Sentia wine product Keypath unchanged 40.8% revenue increase to US$30.4 million   Linius Technologies (ASX:LNU) Cloud...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week At the time...

As well as covering large caps, many brokers also cover smaller companies. In light of this, I thought I would scour through a range of recent notes to see which small cap ASX shares are in favour with brokers at present. Three that have b...

Local stocks closed in the red on Wednesday (as expected), after US stocks posted their biggest fall since June overnight. The ASX 200 threatened to tank early but gained back some ground in afternoon trade to finish 1.08% lower. By sector,...

The ASX 200 closed 1% higher at 7,370 points, a level that saw it nearly recoup losses made earlier this week. The ASX Emerging Companies Index rose 1.64% to close at 2,554 points. All sectors were in the green with the biggest winners bein...

Leader of the ASX health stocks today is Imugene (ASX:IMU) up 4.11% after announcing plans to present its PD1-Vaxx cancer checkpoint immunotherapy program at the ESMO Congress 2021 Annual Meeting in Paris. The company says clinical results...

It was another day of gains for the ASX led by the energy sector. The ASX 200 rose by 0.116% to close at 7,437 while the ASX Emerging Companies Index rose 0.56% to close at 2,527. Although there was an even number of winners and losers amon...

ShareCafeHidden Gems Webinar Recap – Perpetual, OLL, FCT, LBT & MX1 Catch up on the full webinar with a keynote presentation from Perpetual & presentations from OpenLearning (ASX: OLL), First Wave Cloud Technology (ASX: FCT), LBT I...

ShareCafeMiniaturising X-Ray Peter Rowland – Managing Director – Micro-X Ltd is an award-winning ASX listed x-ray technology company. Miniaturising X-RayCompany News

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AFG)) - Australian Finance Group ((BGA)) - Bega Cheese ((BEX)) - BikeExchange ((DTC)) - Damstra holdings ((DDH)) - DDH1 ((GDG)) - Generation Development ((GNX)) - Genex...

Highlights Low interest rate scenario is conducive for growth stocks. The technology sector has witnessed a major tail wind since the rapid digitisation post the COVID-19 outbreak. Knosys is to acquire a leading Library Management Sof...

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

Trading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers and other famous investors over the last fortnight. Specifically, Stockhead tracks substantial shareholder movements, being shareholders hold...

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

We’ve all heard the maxim that ‘time is money’, but in the case of stroke victims ‘time is brain’. From the moment of the dreaded incident, the clock is ticking on getting the patient to a suitably equipped hospital ASAP because millions of...

It wasn’t a happy start to the new financial year for Australia’s bourse, which lost nearly two thirds of one per cent today. Likewise, the ASX200, which rose 22% in FY21, closed down 0.65% to 7,266. Meanwhile, the ASX Emerging Companies In...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Healthcare...